SPECIFIC PHARMA A/S: Financial statements 2023
CVR: 33161395
Source: annual report 2023, Danish Business Authority
01/02/2022 – 31/01/2023
SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 177,609,000 and a net result of DKK 9,876,000 compared with DKK 7,769,000 the year before. That is an increase of 44.1% compared with the year before. The profit margin was 5.6%. Equity in the 2023 report amounted to DKK 89,564,000. The solvency ratio was 85.3%. The company had 25 employees in the financial year.
- Revenue
- DKK 177,609,000
- Gross Profit
- DKK 34,739,000
- Profit/Loss
- DKK 9,876,000
- Equity
- DKK 89,564,000
- Total Assets
- DKK 104,981,000
- Employees
- 25
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 177.6 mio. | 34.7 mio. | 9.9 mio. | 89.6 mio. | 25 |
| 2022 | 123.3 mio. | 26.4 mio. | 7.8 mio. | 85.5 mio. | 23 |
| 2021 | 139.6 mio. | 32.5 mio. | 14.8 mio. | 88.8 mio. | 21 |
| 2020 | 128.2 mio. | 27 mio. | 8.2 mio. | 80.2 mio. | 16 |
| 2019 | 146.4 mio. | 25.3 mio. | 8.9 mio. | 78.6 mio. | 15 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 6, 2023, Ole Markussen has left the board of directors of SPECIFIC PHARMA A/S.
About SPECIFIC PHARMA A/S
SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The board consists of Kristine Sakstrup Haag (chair), Henrik Kaastrup, Kasper Casparij Yde and Ken Rasmussen. The company is owned by NOMECO A/S. The company has 24 employees (2018). In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity in the 2026 report amounted to DKK 98,645,000.